CDKN2A: Options for Managing Cancer Risk
Risk Management for People with Inherited
CDKN2A Mutations
The following are risk management guidelines developed by experts for people with mutations.
We recommend that you speak with a genetics expert who can look at your personal and family history of cancer and can help you determine the best risk management plan. You can learn more about risk management options for different cancers in our section on Screening and Risk Reduction by Cancer Type.
Melanoma screening and prevention guidelines
Beginning Age |
Recommendation |
10 |
|
Source: CDKN2A Mutations: Cancer Risk and Management Recommendations 2020 (2020). UT Southwestern Harold C: Simmons Comprehensive Cancer Center. |
Pancreatic cancer screening options
There are two tests that are used to look for pancreatic cancer in high-risk people.
- MRCP (Contrast-enhanced magnetic resonance cholangiopancreatography) is a special type of imaging that looks closely at the pancreas, liver, gallbladder, bile duct and pancreatic duct to find abnormalities such as cancer.
- EUS (Endoscopic ) involves passing a tiny scope with an attached probe down the esophagus to the stomach. This allows doctors to look closely at the pancreas.
Pancreatic cancer screening guidelines
Beginning Age |
Recommendation |
|
40 (or 10 years younger than the earliest case of pancreatic cancer in the family) |
|
|
Source: NCCN Guidelines: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, Prostate, vs. 3 2025. |
More Resources

Find a Pancreatic Cancer Screening Program
Experts working to improve detection and prevention of hereditary pancreatic cancer.
NCCN Patient Guidelines for Pancreatic Cancer
Expert guidelines to help people with pancreatic cancer make informed decisions.

Find a Dermatologist
Find dermatologists by expertise, location or procedure.
NCCN Patient Guidelines for Melanoma
The National Comprehensive Cancer Network has guidelines to help people diagnosed with melanoma make informed decisions.
Participate in Prevention Research
Below are some of our featured research studies looking at new ways to screen for, prevent or intercept cancer in people with mutations. To search for additional studies, visit our Search and Enroll Tool.

Pancreatic Cancer Screening Study (CAPS5)
Clinicaltrials.gov identifier: NCT02000089

Pancreatic Cancer Early Detection for People at High Risk
Clinicaltrials.gov identifier: NCT04970056

Blood Markers of Early Pancreas Cancer
Clinicaltrials.gov identifier: NCT03568630

Pancreatic Cancer Screening Study for High Risk People
Clinicaltrials.gov identifier: NCT03250078